Telemachus Therapeutics, Inc. raised $375,000 (Wexford, PA)

LIVE PUBLIC DATA Source: SEC EDGAR Form D filings (U.S. Securities and Exchange Commission) · Last refreshed: Wed, 04 Nov 2026 01:28:40 GMT

Telemachus Therapeutics, Inc. plus every comparable record, with all columns and source links, as one CSV.

Not investment advice and not an offer or solicitation to buy or sell any security.

62 / 100 vendor spend propensity

Estimated post-raise budget for CPA / Tax / Audit services: $7,500 (heuristic)

  • Operating company: new capital typically funds hiring, facilities and vendors.
  • Raised $375,000 so far: a smaller raise.
  • Healthcare & Life Sciences companies are a strong fit for CPA / Tax / Audit services.
  • Filed 7 days ago.
  • Incorporated in the last five years: likely still building out finance and insurance.
FieldValue
IndustryPharmaceuticals (Healthcare & Life Sciences)
Operating companyYes
Exemption506(b)
Amount sold$375,000
Total offering$1,500,000
Investors so far3
First sale2026-08-20
Filed2026-10-28 (amendment)
EntityCorporation, incorporated 2026

Executives and related persons (from the filing)

  • Michael Bozik: Executive Officer, Director, Promoter
  • Gregory Hebrank: Executive Officer, Director, Promoter

View the filing on SEC EDGAR

Markdown version

Telemachus Therapeutics, Inc. vs. top 3 peers

OrganizationLocationCapital raisedRecord date
Telemachus Therapeutics, Inc.Wexford$375,0002026-10-28
Tru Singular Health, Inc.Natick$1,000,0002026-10-30
BioLattice Ophthalmics, Inc,Philadelphia$1,825,0002026-10-28
Accufy Diagnostics, Inc.Rockville$2,000,0002026-10-28

Related records

Newly funded companies in Pennsylvania (SEC Form D) Newly funded Healthcare & Life Sciences companies (SEC Form D)

Get new raises like this every morning

FormDPulse emails you newly funded companies that match your ideal customer profile.

See plans

Often used together

Or get the Advisor Prospecting Bundle for $14.99 one-time: Full CSV unlock of newly funded companies plus a grant readiness pack.